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Disruption of neuronal morphology contributes to the pathology of
neurodegenerative disorders such as Alzheimer’s disease (AD). How-
ever, the underlying molecular mechanisms are unknown. Here, we
show that postnatal deletion of Cdh1, a cofactor of the anaphase-
promoting complex/cyclosome (APC/C) ubiquitin ligase in neurons
[Cdh1 conditional knockout (cKO)], disrupts dendrite arborization
and causes dendritic spine and synapse loss in the cortex and hippo-
campus, concomitant with memory impairment and neurodegener-
ation, in adult mice. We found that the dendrite destabilizer Rho
protein kinase 2 (Rock2), which accumulates in the brain of AD pa-
tients, is an APC/CCdh1 substrate in vivo and that Rock2 protein and
activity increased in the cortex and hippocampus of Cdh1 cKO mice.
In these animals, inhibition of Rock activity, using the clinically ap-
proved drug fasudil, prevented dendritic network disorganization,
memory loss, and neurodegeneration. Thus, APC/CCdh1-mediated
degradation of Rock2 maintains the dendritic network, memory
formation, and neuronal survival, suggesting that pharmacolog-
ical inhibition of aberrantly accumulated Rock2 may be a suitable
therapeutic strategy against neurodegeneration.
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The correct formation and long-term maintenance of the den-dritic network are essential for the normal functioning of the
brain. In the adult brain, dendrite stability confers mature neurons
with the ability to maintain long-term dendritic arbor integrity and
integration within networks (1). Loss of dendrite stability is asso-
ciated with psychiatric disorders and neurodegenerative diseases.
Dendritic disruption and loss of dendritic spines and synapses have
been reported in schizophrenia and depression, as well as in neu-
rodegenerative conditions, including Alzheimer’s disease (AD),
and after an excitotoxic insult during stroke (2, 3). The serine-
threonine Rho protein kinase (Rock), an effector of the RhoA
GTPase (4), is a central regulator of the microtubule cytoskeleton
in neurons. Rock is known to modify the number, morphology, and
stability of dendrites in a variety of neuronal cell types, including
cortical neurons (1, 5). The overactivation of Rock signaling an-
tagonizes dendrite stability, whereas Rock inhibition promotes
microtubule assembly and restores dendritic arbor complexity (6–
8). Consistent with these results, Rock has been considered a
promising drug target for central nervous system disorders (4).
However, the molecular mechanism that regulates Rock abun-
dance and activity in neurological disorders is unknown.
The anaphase-promoting complex/cyclosome (APC/C) is a mul-
tisubunit E3 ubiquitin ligase that plays a critical role in controlling
both cell-cycle progression and important functions in postmitotic
neurons (9, 10). APC/C is activated by two alternative regulatory
subunits, namely Cdh1 and Cdc20. In the developing brain, APC/C
is involved in the regulation of neuronal differentiation and survival,
glial differentiation and migration, axonal growth and patterning,
and synapse formation and plasticity (9, 10). In mature neurons,
Cdh1 is the main activator of the APC/C ligase (11). However,
whereas in brain development the functions of APC/CCdh1 are
well-understood (9, 10), its potential functions in the adult brain
are largely unknown.
Here we describe that conditional knockout (cKO) of Cdh1 in
the pyramidal neurons of the cortex and hippocampus of the adult
brain induces dendrite arbor and structure disruption and den-
dritic spine and synapse loss, which results in impaired learning
and memory as well as neurodegeneration. We also found that the
expression level and biochemical activity of Rock2, but not Rock1,
was increased in damaged brain areas of Cdh1 cKO mice. Fur-
thermore, we show that APC/CCdh1 targets Rock2, but not Rock1,
for degradation in the brain. Administration of the clinically
approved Rock inhibitor fasudil to Cdh1 cKO mice prevented
dendrite disruption, dendritic spine loss, impaired memory and
learning, and neurodegeneration. Together, these data reveal
an APC/CCdh1-Rock2 pathway that regulates structural stability and
functional integrity of dendrites, thus posing Cdh1 as a key mo-
lecular factor in the pathogenesis of neurodegenerative disorders.
Results
Cdh1 Deficiency Causes Dendritic Network Disruption and Impaired
Neuronal Connectivity, Leading to Memory and Learning Impairment
in the Adult Brain. Cdh1 is essential for neurogenesis and cortical
size during brain development (12). To study the function of
Cdh1 in the adult brain, here we generated Cdh1 cKO mice by
mating mice harboring a floxed allele of the Cdh1 gene (13) with
CaMKIIα-Cre mice, which express Cre recombinase from the third
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postnatal week in a subset of glutamatergic pyramidal neurons,
including nearly all CA1 hippocampal neurons and in scattered
cortical and other neurons throughout the forebrain (14). Consis-
tent with the temporal activity of the CamKIIα promoter (14),
immunoblotting analyses revealed depletion of Cdh1 levels in the
cortex and hippocampus, but not in the cerebellum, from postnatal
day 25 and continued into adulthood (Fig. 1A). As from postnatal
day 120 the brain weight was reduced (Fig. 1 B and C and Fig.
S1A), as was the cortex (Fig. 1D and Fig. S1B) and the CA1 layer of
the hippocampus, which were thinner in Cdh1 cKO (Fig. 1E and
Fig. S1C). This effect was a consequence of decreased number, not
soma size, of neurons, as judged by stereological counting of
NeuN+ cells (Fig. S1D). Thus, inactivation of APC/CCdh1 in neu-
rons alters age-related growth of the cortex and hippocampus.
Whereas neurogenesis is the main determinant of embryonic
brain growth (12, 15), dendrite length and dendritic arbor com-
plexity are key determinants of adult brain size (16). We found a
reduction in dendrite density in the cortex (Fig. 2A and Fig. S2 A
and C) and hippocampal CA1 layer (Fig. 2B and Fig. S2 B and C)
of Cdh1 cKO mice. Cdh1 knockdown (siCdh1) reduced the den-
drite length of primary cortical neurons (Fig. S2D). Furthermore,
the dendrite disruption in Cdh1 cKO mice at 120 d (Fig. 2 A and B
and Fig. S2C) was not observed in the cerebellum (Fig. S2E), where
Cdh1 levels were unchanged (Fig. 1A and Fig. S2F). In addition,
dendritic complexity (Fig. S2G) of cortical pyramidal neurons was
greatly reduced in Cdh1 cKO mice. Thus, loss of Cdh1 triggers
dendrite disruption and reduces dendrite arborization, suggesting
that Cdh1 is essential for dendritic network integrity and stability in
the adult brain.
Golgi impregnation analyses revealed that Cdh1 cKO mice
displayed lower spine density than controls (Fig. 2C and Fig. S2H).
Moreover, the presynaptic proteins vesicular glutamate transporter
1 (VGlut1) and synaptotagmin 1 (SYT1) and postsynaptic markers
glutamate receptor subunit NR2B and postsynaptic density protein
95 (PSD95) were strongly reduced in the cortex and hippocampus
of Cdh1 cKO mice, indicating synapse loss (Fig. 2D and Fig. S2I).
To evaluate the functionality of the neural pathway integrity, we
recorded cortical electrical activity in the left hemisphere of mice
after sciatic stimulation (17). A marked decrease in the amplitude
of evoked potentials but not in latency was observed (Fig. 2F),
reminiscent of the dysfunctional neural network connectivity that is
observed during neurodegeneration (17). In agreement with this,
Cdh1 deficiency induced neuronal apoptosis (Fig. S3 A and B).
Thus, Cdh1 deficiency in pyramidal neurons disrupts the dendritic
network, leading to dendritic spine and synapse loss, impaired
functional brain connectivity, and neurodegeneration.
Next, we assessed whether Cdh1 cKO mice show impaired
learning, memory, cognition, and anxiety. We observed no differ-
ences in motor coordination (Fig. S4A), but learning and memory,
as judged by validated tests (18), were impaired in Cdh1 cKO mice
(Fig. S4 B and C). These results indicate that Cdh1 loss in the adult
cortex and hippocampus triggers learning and spatial memory
deficits. Because psychiatric disorders and dementia include anxi-
ety (19), we next performed tests (20, 21) and found that
Cdh1 cKO mice showed impaired locomotion/explorative activity
and higher levels of anxiety (Fig. S4 D and E). Altogether, these
data indicate that Cdh1 depletion in pyramidal neurons of the
adult brain impaired hippocampus-dependent spatial learning and
memory, reduced locomotion and exploration activities, and in-
creased levels of anxiety, all of which are consistent clinical signs of
psychiatric diseases and AD (2, 3). Thus, Cdh1 loss-mediated
dendrite arbor disruption in the adult brain may be involved in
the pathogenesis of these neurological disorders.
Fig. 1. Conditional knockout of Cdh1 from the adult forebrain reduced
thickness of the cerebral cortex and CA1 hippocampal layer. (A) Immunoblotting
analyses reveal Cdh1 down-regulation in the cortex (Cx) and hippocampus (Hy),
but not in the cerebellum (Cb), of cKO Cdh1 from postnatal day 25 and con-
tinued into adulthood. (B and C) Genetic ablation of Cdh1 in the adult forebrain
did not modify body weight (B) but significantly reduced brain weight from the
age of 120 d (C). (D and E) Brain sections were immunostained with the neu-
ronal marker NeuN. (D) Cerebral cortex from Cdh1 cKO mice failed to grow
normally, resulting in a marked reduction of cortical thickness from 120 d after
birth. White dashed lines mark cortex thickness. (Scale bars, 100 μm.) (E) The
CA1 layer of the hippocampus was thinner in the Cdh1 cKO from 120 d of age,
compared with age-matched control mice. (Scale bars, 200 μm; magnification:
Insets, 20×.) Data are expressed as mean ± SEM; *P < 0.05 versus age-matched
control mice (one-way ANOVA followed by the Bonferroni post hoc test; n =
6 mice per group).
Fig. 2. Cdh1 deficiency triggers dendrite disruption and loss of dendritic spines
and synapses in the adult brain. (A and B) Cdh1 loss triggered dendrite dis-
ruption in both the cortex (A) and hippocampal CA1 layer (B) of 120-d-old mice,
as revealed by immunostaining for the dendritic marker Map2. [Scale bars,
50 μm (A, Top), 10 μm (A, Bottom), 50 μm (B, Top), 15 μm (B, Bottom).] (C) Golgi
impregnation of brain sections showed dendritic spine loss in cortical pyramidal
neurons of 120-d-old Cdh1 cKO mice, compared with control mice. (Scale bars,
10 μm.) (D) Cdh1 depletion triggered synapse loss, as revealed by the reduction
in levels of the presynaptic proteins vesicular glutamate transporter 1 and
synaptotagmin 1 and postsynaptic markers glutamate receptor subunit NR2B
and postsynaptic density protein 95 in the cortex and hippocampus. (E) Cdh1
deficiency caused a marked decrease in evoked potential amplitude, whereas
latency was not modified. Data are expressed as mean ± SEM; *P < 0.05 versus
control mice (Student’s t test; n = 4 to 6 mice per group).
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APC/CCdh1 Triggers the Ubiquitin-Dependent Degradation of the Dendrite-
Destabilizing Protein Rock2. The activation of Rho signaling through
Rock plays the role of a central mediator of dendrite destabilization
(1, 4, 22). We noticed that both Rock isoforms, Rock1 and Rock2,
contain a conserved KEN box motif, which targets proteins for
ubiquitination by the ubiquitin ligase APC/CCdh1 (9). Hence, we
analyzed Rock1 and Rock2 protein levels in the brains of Cdh1 cKO
and wild-type mice using specific and validated antibodies (Fig. S5A)
(23). We found both Rock1 and Rock2 proteins to be expressed in
the cortex and hippocampus of wild-type mice (Fig. 3A). However,
Rock2, but not Rock1, increased at 120 and 360 d in Cdh1 cKO
mice, an effect that was correlated with dendrite disruption (Fig. 3A
and Fig. S5B). Because this result suggests that Cdh1 may regulate
levels of Rock2 but not those of Rock1, we next silenced Cdh1 in
primary neurons. siCdh1 caused an increase in Rock2 but not in
Rock1 (Fig. S5C). Inhibition of APC/C activity in cortical primary
neurons (Fig. S5C) and cortical and hippocampal slices (Fig. S5D)
also increased Rock2, but not Rock1, protein abundances.
Next, we ascertained whether Rock2 was regulated by APC/CCdh1
activity via ubiquitination and proteasomal degradation. Immuno-
precipitation of the APC/C core subunit APC3, in Cdh1 cKO or
control mice, followed by immunoblotting against Rock1 or Rock2,
revealed that APC/CCdh1 forms a complex with Rock2 but not with
Rock1 (Fig. 3B). Because the APC/CCdh1 recognition motif, the
KEN box, is conserved both in Rock1 and Rock2, we next aimed
to resolve this apparent paradox. In cancer cells, Rock1 is pre-
sent in the cytosol and Rock2 both in the nucleus and cytosol
(23, 24); however, APC is present only in the nucleus (25, 26).
Nucleus–cytosol fractionation of primary cortical neurons revealed
that Rock2 is present in the nucleus and, more abundantly, in the
cytosol; however, Rock1 is exclusively present in the cytosol (Fig.
S5E). Interestingly, APC3 and Cdh1 were found in the nucleus, but
not in the cytosol (Fig. S5E). The modestly shifted band of Cdh1 in
the cytosol (Fig. S5E) likely reflects a hyperphosphorylated—
inactive—form of Cdh1 (27). Furthermore, APC3 immunopre-
cipitation in the nuclear and cytosolic neuronal fractions, followed
by immunoblotting against Rock1 and Rock2, revealed that the
interaction between APC3 and Rock2 only occurred in the nu-
cleus; however, no interaction between APC3 and Rock1 occurred
either in the nucleus or the cytosol (Fig. S5E). Together, these data
indicate that, at least in primary neurons and in the in vivo brain,
Rock2, but not Rock1, is an APC/CCdh1 substrate.
To ascertain whether APC/CCdh1 targets Rock2 protein for deg-
radation, cortical and hippocampal slices from wild-type mice were
first incubated in the presence of the proteasome inhibitor MG132,
which resulted in Rock2 protein accumulation (Fig. S5F), indicating
that Rock2 normally undergoes proteolysis. Rock2 immunoprecipi-
tation confirmed substantial Rock2 ubiquitination in the hippocam-
pus and cortex of wild-type mice; however, the levels of ubiquitinated
Rock2 were significantly lower in cKO Cdh1 mice (Fig. 3C). To
confirm Rock2 ubiquitination, we then performed in-cell (HEK293T)
ubiquitination assays. Rock2 showed a smeared pattern of ubiquiti-
nated bands that was substantially attenuated in the presence of
proTAME (Fig. 3D). Expression of mutant Rock2, in which the KEN
motif was substituted by an AAA sequence (Rock2-mut), disrupted
the interaction of Rock2 with Cdh1 (Fig. 3E) and attenuated the
smeared pattern of ubiquitinated bands in immunoprecipitated
Rock2 (Fig. 3F), indicating the direct participation of the KEN box in
Rock2 interaction with Cdh1. Altogether, these data demonstrate
that, by recognizing the KEN box, APC/CCdh1 ubiquitinates Rock2,
targeting it for proteasomal degradation.
APC/CCdh1 Controls Dendritic Network Integrity via the Regulation of
Rock2 Activity. Given that APC/CCdh1 regulates Rock2 levels and
activity, we next were prompted to investigate whether the control
of dendritic network integrity by APC/CCdh1 occurred via Rock2
activity. First, we aimed to ascertain whether the increased protein
levels of Rock in the brain of Cdh1 cKO mice correlated with
Rock2 activity, as measured by its ability to specifically phosphor-
ylate Thr853 of myosin phosphatase myosin-binding subunit (MBS)
(23). As shown in Fig. S5G, neuronal Cdh1 loss triggered Rock2
activation in the hippocampus and cortex of the adult brain, in-
dicating that APC/CCdh1 regulates Rock2 levels and activity in the
adult brain. Next, we took advantage of fasudil, a clinically approved
drug that, by inhibiting Rock activity, improves the clinical outcome
of ischemic stroke patients (28). We found that i.p. administration
of fasudil for 2 mo starting at postnatal day 30 strongly inhibited
Rock2 activity in the cortex and hippocampus, as judged by its
ability to fully prevent Thr853 MBS phosphorylation (Fig. S5G).
Immunostaining against the neuronal markers NeuN and Map2 of
brain sections of Cdh1 cKO mice revealed that fasudil treatment
partially rescued the reduced thickness and neuronal number of the
cerebral cortex (Fig. 4 A and C and Fig. S6A) and hippocampal
CA1 layer (Fig. 4 B and D and Fig. S6A). Furthermore, fasudil
prevented Cdh1 depletion-induced dendrite disruption in both the
cortex and CA1 layer of the hippocampus (Fig. 4E and Fig. S6B) of
the adult brain, as revealed by Map2 immunostaining. To confirm
these results using a more sensitive technique, Cdh1 cKOmice were
cross-bred with mice expressing YFP as a volume label in pyramidal
neurons of the hippocampus and in layer 5 of the cerebral cortex
(29). Immunostaining against GFP confirmed the dendrite disrup-
tion and neuronal loss in the cortex (layer 5) and hippocampus
(CA1 layer) (Fig. 4F and Fig. S6C) of Cdh1 cKO mice, which were
partially prevented by fasudil. Finally, we observed that fasudil also
prevented dendritic spine loss in pyramidal neurons in the cortex of
Cdh1 cKO mice (Fig. 4G and Fig. S6D). Interestingly, we noticed
Fig. 3. APC/CCdh1 triggers the ubiquitination of Rock2. (A) Cdh1 depletion in
the cortex and hippocampus did not alter RhoA and Rock1 expression, but age-
dependent increases in Rock2 levels and decreases in Map2 levels from 120 d of
age were seen. (B) Endogenous coimmunoprecipitation analyses revealed that
the core subunit of APC/C, APC3, interacts with endogenous Rock2 and Cdh1,
but not with Rock1, in the hippocampus and cortex from 120-d-old control
mice. (C) Immunoprecipitation of Rock2 followed by immunoblotting with the
anti-ubiquitin (Ub) antibody revealed that endogenous Rock2 was ubiquiti-
nated in the hippocampus and cortex from control mice. (D) Lysates of
293T cells transfected with hemagglutinin-ubiquitin (HA-Ub) and wild-type
Rock2 (Myc-Rock2-wt) and pretreated with proTAME (10 μM) and MG132
(20 μM) for 2 h were immunoprecipitated with anti-Myc agarose beads fol-
lowed by immunoblotting with HA and Myc antibodies. (E) 293T cells were
transfected with Myc-Rock2-wt or Myc-Rock2-mut (KEN box mutated to AAA),
together with HA-Cdh1, and were immunoprecipitated with HA agarose beads
followed by immunoblotting with Myc and HA antibodies. Coimmunoprecipi-
tation analysis revealed that Cdh1 formed a complex with wild-type Rock2 but
not with the KEN box mutant of Rock2. (F) 293T cells transfected as in E and
pretreated with MG132 (20 μM for 2 h) were immunoprecipitated with anti-
Myc agarose beads followed by immunoblotting with HA and Myc antibodies.
IB, immunoblotting; IP, immunoprecipitation.
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that fasudil caused a slight loss of neurons in control mice, as
revealed by GFP staining in the cortex and hippocampus (Fig. 4F
and Fig. S6C), likely reflecting that trace amounts of Rock activity
are essential for optimal neural structure integrity. In addition, it
should be noted that fasudil inhibits both Rock1 and Rock2 activ-
ities. However, selective silencing of Rock2 (Fig. S5A) abolished the
neurite disruption observed in Cdh1–knocked-down primary neu-
rons (Fig. S6E), as judged by quantification of the average neurite
length (Fig. S6F) and number (Fig. S6G) per neuron. This suggests
that the impact of Rock1, which is present in Rock2-silenced neu-
rons (Fig. S5A), on Cdh1 loss-mediated dendrite disruption is
negligible, at least in primary neurons. In contrast, selective silenc-
ing of Rock1 (Fig. S5A) had no effect on Cdh1 loss-mediated
neurite disruption (Fig. S6 E–G). Thus, although we cannot un-
ambiguously disregard a possible effect of Rock1 inhibition by
fasudil in vivo, our data suggest that its effect on dendritic integrity
is specifically mediated by Rock2 inhibition. Altogether, our data
indicate that Cdh1 depletion in pyramidal neurons of the adult
brain increases Rock2 protein and activity, leading to dendrite
disruption, dendritic spine loss, and neurodegeneration in the adult
brain. Interestingly, fasudil mitigated the locomotion/explorative
activity impairment and attenuated anxiety caused by Cdh1 (Fig. 5
A and B and Fig. S6H), as well as improved the learning and
memory impairment caused by Cdh1 loss (Fig. 5C). It should be
noted that fasudil slightly worsened locomotion and anxiety (Fig. 5
A and B and Fig. S6H) and learning and memory (Fig. 5C) in
control mice, confirming the importance of baseline Rock activity
for neural integrity and function. Together, our data indicate that
depletion of Cdh1 in pyramidal neurons increases Rock2 protein
levels and activity in adulthood, causing dendrite network disrup-
tion, anxiety, and impaired learning and memory.
Discussion
We describe a signaling pathway in which the E3 ubiquitin ligase
APC/CCdh1 controls the stability and integrity of neuronal den-
drites in the adult brain by destabilizing the Rho kinase protein
Rock2. Thus, knockout of Cdh1, specifically in the pyramidal
neurons of the cerebral cortex and hippocampus, induces dendrite
structure disruption and dendritic spine and synapse loss, resulting
in impaired neuronal connectivity, deficits in learning and memory,
and neurodegeneration. Furthermore, we identify that the mediator
of dendrite destabilization, Rock2, is an APC/CCdh1 substrate in
vivo by direct interaction between Cdh1 and Rock2 through its
KEN box. Thereby, depletion of Cdh1 in pyramidal neurons trig-
gers accumulation and activation of Rock2 in the affected areas of
the adult brain. Finally, administration of the clinically approved
Rock inhibitor fasudil prevents dendrite disruption, impaired
learning and memory, and neuronal loss induced by Cdh1 knock-
out. Our results therefore demonstrate an APC/CCdh1-Rock2
signaling pathway that regulates structural and functional integrity
of the dendritic network in the adult forebrain.
Fig. 4. Rock2 inhibition with fasudil improves dendrite disruption in the
Cdh1 cKO cortex and hippocampus. The Rock inhibitor fasudil (20 mg/kg) was
injected intraperitoneally every other day into 30-d-old mice for 2 mo. (A and B)
Brain sections were immunostained for the neuronal marker NeuN. Fasudil
treatment prevented the reduced thickness of the cerebral cortex (A) (white
dashed lines mark cortex thickness) and hippocampal CA1 layer (B) induced by
Cdh1 depletion in 120-d-old mice. [Scale bars, 100 μm (A) and 200 μm (B);
magnification: B, Insets, 20×.] (C and D) The cortex (C) and CA1 layer of the
hippocampus (D) from one hemisphere of 120-d-old mice were dissected and the
number of neurons was estimated using the isotropic fractionator method.
Cdh1 loss induced neuronal loss, which was partially prevented by fasudil treat-
ment. (E) Brain sections were immunostained for the dendritic marker Map2.
Fasudil treatment prevented Cdh1 depletion-induced dendrite disruption in the
cortex and CA1 layer of the hippocampus. (Scale bars, 20 μm.) (F) Immunos-
taining for GFP in brain sections of control-YFP and Cdh1 cKO-YFP triple-
transgenic mice revealed that Cdh1 depletion triggered neurite disruption and
loss of pyramidal neurons in the cortex (layer 5) and hippocampus (CA1 layer),
which were partially prevented by fasudil treatment. [Scale bars, 100 μm (layer 5)
and 20 μm (CA1 layer).] (G) Golgi impregnation of brain sections showed that
fasudil treatment prevented dendritic spine loss caused by Cdh1 depletion in
cortical pyramidal neurons of 120-d-old mice. (Scale bars, 10 μm.) Data are
expressed as mean ± SEM; #P < 0.05 versus Cdh1 cKO mice (one-way ANOVA
followed by the Bonferroni post hoc test; n = 4 mice per group).
Fig. 5. Treatment with the Rock2 inhibitor fasudil improves behavioral deficits
in Cdh1 cKO mice. Fasudil (20 mg/kg) was injected intraperitoneally every other
day into 30-d-old mice for 2 mo. (A) Representative images showing the ex-
plorative behavior of mice in the open-field task. Fasudil partially prevented the
reduction in total distance moved and number of rears and the increase in time
spent immobile (freezing) caused by Cdh1 loss. (B) Cdh1 depletion-mediated
reduction in distance moved and number of head dips into holes in the hole-
board test was improved by fasudil treatment. (C) Rock2 inhibition by fasudil
partially prevented the increase in the latency to enter the goal box and the
number of errors across trials in the Lashley III maze test found in cKO Cdh1mice.
Data are expressed as mean ± SEM; #P < 0.05 versus Cdh1 cKO mice (one-way
ANOVA followed by the Bonferroni post hoc test; n = 6 mice per group).
4516 | www.pnas.org/cgi/doi/10.1073/pnas.1616024114 Bobo-Jiménez et al.
Interestingly, at postnatal day 25, Cdh1 cKO mice exhibited nor-
mal, mature dendrite structure and branching in cortical and hip-
pocampal CA1 pyramidal neurons. This contrasts with the reduced
cortical size and microcephaly phenotype upon deletion of Cdh1 seen
at embryonic stages (12). Thus, in the developing brain, the stabili-
zation of dendrites critically depends on synapse formation, whereas
in the mature nervous system, dendritic network stability depends on
the microtubule cytoskeleton (1). Nevertheless, the normal dendrite
structure observed in Cdh1 cKO mice at postnatal day 25 was not
maintained afterward, when dendrite disruption, loss of dendritic
branches, and dysfunction of neural network connectivity occurred.
These changes caused a thinning of anatomical layers in the cortex
and hippocampus in adult mice, as it has been reported that dendrite
disruption and reduced dendritic arbor complexity determine brain
size in adult animals (16). Furthermore, the reduction in dendritic
spine density and synapses altered synaptic connectivity that, in the
hippocampus, likely contributed to the anxiety and impaired learning,
cognition, and memory phenotypes that recapitulate the alterations
seen in a variety of psychiatric and neurodegenerative disorders
(2, 3). Thus, APC/CCdh1 maintains structural and functional integrity
of dendritic networks, suggesting that Cdh1 is important for the
molecular pathogenesis of memory disorders.
The identification of the microtubule-destabilizing protein Rock2
as an APC/CCdh1 substrate may have important implications for our
understanding of the mechanism behind dendrite stability in the
adult brain. Dendritic microtubules are enriched in microtubule-
associated protein Map2, which promotes microtubule polymeri-
zation and dendritic arbor stabilization (1, 30, 31). Even though
Rock2 disrupts dendrite architecture through several possible
mechanisms, it is known that loss of Map2-mediated microtubule
instability is an important contributing factor in Rock2-induced
dendrite arbor disruption (1, 5). Thus, Rock2 phosphorylates
Map2 at Ser1796 (32), a critical residue at the microtubule-binding
region, thus reducing its ability to bind microtubules for correct
assembly (32, 33). We show that conditional KO of Cdh1 promoted
an age-dependent reduction in Rock2 levels, thus correlating with
Map2 loss and dendrite disruption. Notably, reduction of dendritic
arbor complexity and loss of dendritic spines were prevented by
administration of the Rock2 inhibitor fasudil to Cdh1 cKO mice.
Therefore, we can conclude that APC/CCdh1 promotes the degra-
dation of Rock2 to ensure proper stability of dendrites and main-
tenance of dendritic arbors and synapses in the adult brain.
Plasticity of neural circuits relies on dynamic changes in the
cytoskeleton of dendritic spines (34), in which Rock2 plays a
pivotal role. The RhoA-Rock2 pathway mediates remodeling of
dendritic spine morphology and density downstream of glutamate
receptor activation (35, 36). Therefore, the APC/CCdh1-Rock2
signaling pathway is consistent with the previously described effect
of APC/CCdh1 on synaptic plasticity, including long-term po-
tentiation, mGluR-dependent long-term depression, and ho-
meostatic synaptic plasticity (10, 37–39).
Human neuropathology data reveal that dendritic defects in
AD—including dendrite disruption, reduced arbor complexity, and
loss of spines—are widespread and occur early in the disease (40).
Interestingly, we have observed these features in Cdh1 cKO mice.
It has also been suggested that the pathological outcome of neu-
rodegenerative conditions is not necessarily originated by neuronal
loss but by subtle changes in dendrites and spines and/or synapses
that limit neuronal functionality within the network (3). Moreover,
the gradual loss of microtubule mass in neurons is thought to occur
by destabilization and depolymerization of microtubules, leading to
dendrite disruption (41). Our findings that APC/CCdh1 controls the
stability of Rock2 in neurons support this notion, and identify a
potential therapeutic target against AD. Interestingly, although no
effective therapy is known to combat the progression of AD,
studies in animal models provide strong evidence that maintaining
dendritic network integrity may ease the symptoms and slow down
disease progression (3, 42). Furthermore, Rock2 levels increase in
the very early stages of AD and remain elevated throughout the
course of the disease (43), and Rock2 inhibition reduces amyloid-β
levels (43, 44) and attenuates amyloid-β–induced neurodegenera-
tion (45). Therefore, the reduction in dendrite disruption, and the
improvement in learning and memory observed after fasudil ad-
ministration to Cdh1 cKO mice, further supports the notion that
this clinically approved Rock inhibitor drug should be considered
as a drug to treat AD.
In conclusion, here we describe an APC/CCdh1-Rock2 signaling
pathway that regulates structural and functional integrity of the
dendritic network in the adult forebrain, which may have important
implications for the pathology of psychiatric and neurodegenerative
disorders. Importantly, we have previously described that glutamate
receptor overactivation, a hallmark of neurodegenerative diseases,
promotes Cdk5-induced Cdh1 phosphorylation (9, 27) and in-
activation, which may explain the accumulation of Rock2 that has
been found in these disorders (43). Therefore, pharmacological
inhibition of aberrantly accumulated Rock2 with fasudil treatment
may be a suitable therapeutic strategy against these neurological
diseases. Beyond neural tissue, it is known that Rock activity,
through its actions on cytoskeletal dynamics, promotes tumor cell
invasion and metastasis (46, 47). Whether the APC/CCdh1-Rock2
pathway also represents a new mechanism in cancer progression is
a tempting possibility that remains to be elucidated.
Materials and Methods
CamKIIalpha-Cre–Mediated Cdh1 Conditional Knockout Mice. The Cdh1lox/lox-
targeted mouse model (13) was crossed with transgenic mice carrying the gene
encoding Cre recombinase under the control of the Camk2α-cre promoter (14)
(SI Materials and Methods).
All animals were bred and maintained at the Animal Experimentation
Service of the University of Salamanca in accordance with Spanish legislation
(RD 53/2013). Procedures and protocols have been approved by the research
Bioethics Committee of the University of Salamanca.
Cell cultures and transfections. Primary cultures of cortical neurons (12) and trans-
fections (27) were prepared as previously described (SI Materials and Methods).
Coimmunoprecipitation assay. Immunoprecipitation of endogenous (39) and
exogenous (27) proteins was performed as previously described (SI Materials
and Methods).
Rock2 ubiquitination assay. Tissue slices were incubated with MG132 (20 μM) for
1 h, and cortex and hippocampus were microdissected, lysed, and immuno-
precipitated with anti-Rock2 antibody, followed by immunoblotting with anti-
ubiquitin antibody (39) (SI Materials and Methods).
Immunohistochemistry. Immunohistochemistry was performed according to a
previously published protocol (48) (SI Materials and Methods).
Neuronal counting. Brain areas of interestwere identifiedas in Paxinos andWatson
(49) in NeuN-stained 40-μm-thick sections and used for cell counting by an author
blinded to genotype and treatment (50, 51) (SI Materials and Methods).
Behavioral studies. One hundred and twenty-day-old mice were handled for 3 d
to acclimate them to the experimenter before subjecting them to the exper-
imental procedures. All behavioral procedures were video-recorded and scored
by an individual blind to the genotypeof themouse (SIMaterials andMethods).
Statistical Analysis. The results are expressed asmeans± SEM.Aone-wayANOVA
followed by the Bonferroni post hoc test was used for pairwise comparisons
within multiple samples. The Student’s t test was used to compare the means of
two independent groups. In all cases, P values < 0.05 were considered significant.
Statistical analysis was performed using SPSS Statistics 22.0 for Macintosh.
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